Judging the safety of aprotinin.
Rieves
R Dwaine
RD
Weiss
Karen D
KD
D026683:Advisory Committees; D000933:Antifibrinolytic Agents / Q000009:adverse effects*; D007611:Aprotinin / Q000009:adverse effects*; D003627:Data Interpretation, Statistical; D017277:Drug Approval; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced; D051437:Renal Insufficiency / Q000139:chemically induced*; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
D000933:Antifibrinolytic Agents; D007611:Aprotinin